Chris Reidy
Chris Reidy
Boston Globe Staff
Reidy is a general assignment business reporter for the Boston Globe. He chiefly contributes to online coverage that focuses on breaking local business news. In the past, he has covered beats such as retail, advertising, and residential real estate.

Stories by Chris Reidy

Raise for Raze

Cambridge-based Raze Therapeutics announced its launch Monday, adding that it has closed on a $24 million Series A financing.

Investors in the Series A financing include Atlas Venture, MPM Capital Management, MS Ventures, Partners Innovation Fund, Astellas Venture Management, and Novartis, the Raze press release said.

Atlas partner Jason Rhodes is Raze’s acting chief executive.


Intarcia secures $200m round of funding for its treatment of type 2 diabetes
Intarcia's matchstick-sized mini-pumps are inserted under the skin to deliver its drug for controlling type 2 diabetes. (Company photo)
Intarcia Therapeutics Inc., a biotechnology company that recently opened a headquarters office at the Boston Innovation Center to take advantage of the region’s deep pool of life sciences talent, said Tuesday that it has completed a private round of equity financing for $200 million, one of the largest investments in Massachusetts in recent years.. Read More
make it rain
RainDance adds $16.5M for new biopsy technology
Image taken from RainDance website.

RainDance Technologies Inc., a Billerica company using genomics tools to design tests for the early detection of cancer and other diseases, said that it has closed a $16.5 million Series E financing round extension.

New investors include GE Ventures and Northgate Capital. All existing financial investors participated in the round as well, RainDance said in a press release.

Read More